9.700
+0,00%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +521.6% | +96.6% | 1 / 3 | +64.6% | +2.49 pp | +4.25 pp | +15.3% | 0.38 | 3.28 | 134 | +64,6% | 7,8 | +521,6% | 3.28 | 5.34 | −38,5% |
| Pts | 12 | 12 | 4 | 12 | 8 | 12 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 9.700 (close price on 2026-10-19)EPS (TTM): 2.955
Financial charts
1.Revenue & growth
VND bn134Q2/26
1.Revenue & growth
VND bn134Q2/26
2.Profit & growth
VND bn7,76Q2/26
3.Profit mix (Penman)
VND bn20,6Q2/26
4.Margins & cost structure
%14.7%Q2/26
5.Returns & cash cycle
% · days11.6%Q2/26
6.Earnings quality & cash
VND bn48,3Q2/26
7.Asset structure
VND bn228Q2/26
8.Funding & debt health
VND bn · times228Q2/26
9.Revenue backlog
VND bn16,7Q2/26
10.Valuation
times · %3,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.394Q2/26
Adjusted EPS growth, latest quarter
522%
Average adjusted EPS growth, 3 quarters
96.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26